Clinical data | |
---|---|
Trade names | Nipride, Nitropress, others |
Other names | SNP |
AHFS/Drugs.com | Monograph |
License data |
|
Pregnancy category |
|
Routes of administration | Intravenous |
ATC code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Bioavailability | 100% (intravenous) |
Metabolism | By haemoglobin being converted to cyanmethaemoglobin and cyanide ions |
Onset of action | nearly immediate[3] |
Elimination half-life | <2 minutes (3 days for thiocyanate metabolite) |
Duration of action | 1 to 10 minutes[3] |
Excretion | kidney (100%; as thiocyanate)[4] |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.119.126 |
Chemical and physical data | |
Formula | C5FeN6Na2O |
Molar mass | 261.921 g·mol−1 |
3D model (JSmol) | |
Density | 1.72 g/cm3 |
Solubility in water | 100 mg/mL (20 °C) |
| |
|
Sodium nitroprusside (SNP), sold under the brand name Nitropress among others, is a medication used to lower blood pressure.[3] This may be done if the blood pressure is very high and resulting in symptoms, in certain types of heart failure, and during surgery to decrease bleeding.[3] It is used by continuous injection into a vein.[3] Onset is nearly immediate and effects last for up to ten minutes.[3]
It is available as a generic medication.[5]
GG
was invoked but never defined (see the help page).